Literature DB >> 19436104

Respiratory gating with EPID-based verification: the MDACC experience.

Tina Marie Briere1, Sam Beddar, Peter Balter, Ravi Murthy, Sanjay Gupta, Christopher Nelson, George Starkschall, Michael T Gillin, Sunil Krishnan.   

Abstract

We have investigated the feasibility and accuracy of using a combination of internal and external fiducials for respiratory-gated image-guided radiotherapy of liver tumors after screening for suitable patients using a mock treatment. Five patients were enrolled in the study. Radio-opaque fiducials implanted adjacent to the liver tumor were used for daily online positioning using either electronic portal or kV images. Patient eligibility was assessed by determining the degree of correlation between the external and internal fiducials as analyzed during a mock treatment. Treatment delivery was based on the modification of conventional amplitude-based gating. Finally, the accuracy of respiratory-gated treatment using an external fiducial was verified offline using the cine mode of an electronic portal imaging device. For all patients, interfractional contribution to the random error was 2.0 mm in the supero-inferior direction, which is the dominant direction of motion due to respiration, while the interfractional contribution to the systematic error was 0.9 mm. The intrafractional contribution to the random error was 1.0 mm. One of the significant advantages to this technique is improved patient set-up using implanted fiducials and gated imaging. Daily assessment of images acquired during treatment verifies the accuracy of the delivered treatment and uncovers problems in patient set-up.

Entities:  

Mesh:

Year:  2009        PMID: 19436104     DOI: 10.1088/0031-9155/54/11/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

Review 3.  Adaptive management of liver cancer radiotherapy.

Authors:  Kristy K Brock; Laura A Dawson
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

Review 4.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

5.  Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.

Authors:  Michael Velec; Joanne L Moseley; Laura A Dawson; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

6.  Evaluation of relative transmitted dose for a step and shoot head and neck intensity modulated radiation therapy using a scanning liquid ionization chamber electronic portal imaging device.

Authors:  Mohammad Mohammadi; Eva Bezak
Journal:  J Med Phys       Date:  2012-01

Review 7.  Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases.

Authors:  Paul B Romesser; Neelam Tyagi; Christopher H Crane
Journal:  Cancers (Basel)       Date:  2021-04-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.